STAT

STAT+: Roivant lung disease drug hits mid-stage study goals

STAT+: Roivant lung disease drug hits mid-stage study goalsWorldPing

These positive results could open up a new way to treat serious lung disease.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news